ARK Investment Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,241,979
Closed -$36M 234
2023
Q4
$36M Buy
14,241,979
+1,258,977
+10% +$2.93M 0.21% 60
2023
Q3
$31M Buy
12,983,002
+288,777
+2% +$639K 0.24% 52
2023
Q2
$29.3M Buy
12,694,225
+1,080,616
+9% +$3.05M 0.19% 61
2023
Q1
$29.6M Buy
11,613,609
+2,553,381
+28% +$7.32M 0.2% 54
2022
Q4
$22.7M Sell
9,060,228
-1,957,444
-18% -$5.46M 0.2% 65
2022
Q3
$32M Buy
+11,017,672
New +$46.4M 0.22% 59
2022
Q2
Sell
-10,390,335
Closed -$61.8M 359
2022
Q1
$83.3M Buy
10,390,335
+1,558,516
+18% +$13.7M 0.35% 49
2021
Q4
$103M Buy
8,831,819
+2,497,507
+39% +$29.9M 0.31% 57
2021
Q3
$78.5M Buy
+6,334,312
New +$71.4M 0.19% 80

ARK Investment Management's SLGC Position: Q1 2024 in Review

ARK Investment Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 14,241,979 shares — an estimated $36M sold.

ARK Investment Management first reported a position in SLGC in Q3 2021 and held it in 9 quarters. The position peaked at $103M in Q4 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • ARK Investment Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • ARK Investment Management sold 14,241,979 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $36M.
  • ARK Investment Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 9 quarters.
  • ARK Investment Management's SomaLogic, Inc. Class A Common Stock position peaked at $103M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on ARK Investment Management's 13F filing for Q1 2024, filed 18 Apr 2024.